170 IndexFine-needle aspiration, of thebreast (cont.)normal cytologic constituentsin, 5, 6, 9, 10–11specimen adequacy in, 14technical aspects of, 3–15Fine-needle aspiration reports,7in proliferative breastdisease, 26–28Fistula, chronic subareolarabscess-related, 17Foreign-body reactions, 18Fungal infections, asgranulomatous mastitiscause, 18GGastric cancer, metastatic, 143Gastrointestinal tumors,differentiated fromsignet ring carcinoma,104Giant cells, osteoclastic-type,127–128Glycogen-rich carcinomaclear-cell, 121differentiated from lipid-richcarcinoma, 107Granular cell tumors, 74–75differential diagnoses ofapocrine carcinoma, 124fibrocystic changes, 75inflammatorymyofibroblastic tumors,52, 75metaplastic carcinoma, 75Granulation tissue, 35differentiated fromangiosarcoma, 133Granulomata, “silicone,”29, 31Granulomatous reactionsmastitis-related, 18to ruptured silicone implants,29, 31“Gray zone diagnosis,” 1–2,27–28apocrine carcinoma as, 123benign sources of, 27malignant sources of, 28Gynecologic cancers, 138Gynecomastia, 46–51clinical features of, 47cytomorphologiccharacteristics of, 47–49definition of, 46differential diagnoses of, 50as “gray zone diagnosis”cause, 27HHamartoma, 82–83Hemangioma, atypical, 133Hematologic tumors,139–142clinical features of, 139cytomorphologiccharacteristics of, 139,140–142differential diagnoses of, 139,142Hematoma, 5, 133Hemorrhage, fine-needleaspiration-related, 5Her2neu, 2Hibernoma, 78Hidradenomaclear-cell, 121malignant nodular, 130, 131,132Histiocytes, differentiated fromgranular cell tumors,75
Index 171Human immunodeficiencyvirus-positive patients,47Hyperplasiaductal. See Ductalhyperplasialobular. See Lobularhyperplasiapseudoangiomatous stromal.See Pseudoangiomatousstromal hyperplasiaIInfection, fine-needleaspiration-related, 5Inflammatory carcinoma, 120Inflammatory conditions, of thebreast, 16–18Inflammatory myofibroblastictumors, 51–52differential diagnoses of, 52,75, 79LLactation-related breastchanges, 43–46differential diagnoses ofinflammatory breastconditions, 120lobular carcinoma in situ,98secretory carcinoma, 116as mastitis cause, 16Lactiferous ductslow-grade/mild infection of,17subareolar papilloma of, 67Leukemia, 149Lipid-rich/lipid-secretingcarcinomadifferential diagnoses of,107glycogen-rich, clear cellcarcinoma, 121signet ring carcinoma, 104,105Lipoma, 5, 77–78clinical features of, 77–78cytomorphologiccharacteristics of, 78differential diagnoses of, 32,78Lobular carcinoma, 96–103differential diagnoses ofinvasive ductal carcinomanot otherwise specified(NOS), 96lactation-related breastchanges, 46radiation-related breastchanges, 39with fibroadenoma, 57in situ, 96–98invasive, 98–103carcinoma in situassociated with, 99, 100clinical features of, 98–99cytomorphologic featuresof, 98, 99–103differential diagnoses of,103, 104, 105, 118, 130,139false-negative diagnosis of,103as “gray zone diagnosis,”28histologic features of, 99Lobular hyperplasiaatypical, 39differential diagnoses of,39, 46, 98, 103proliferative breast diseaserelated,25Lobular neoplasia, 103
- Page 2 and 3:
Breast Cytopathology
- Page 4 and 5:
Syed Z. Ali, MDDepartment of Pathol
- Page 6 and 7:
To my parentsGul Bano (late) and Ma
- Page 8 and 9:
viiiForewordthis volume to rejuvena
- Page 10 and 11:
xSeries Prefaceand form the framewo
- Page 12 and 13:
xiiPrefacecarefully selected high-r
- Page 14 and 15:
ContentsForeword by Dorothy L. Rose
- Page 16 and 17:
2 1. Introduction and Technical Asp
- Page 18 and 19:
4 1. Introduction and Technical Asp
- Page 20 and 21:
6 1. Introduction and Technical Asp
- Page 22 and 23:
8 1. Introduction and Technical Asp
- Page 24 and 25:
10 1. Introduction and Technical As
- Page 26 and 27:
12 1. Introduction and Technical As
- Page 28 and 29:
14 1. Introduction and Technical As
- Page 30 and 31:
2Non-neoplastic andProliferative Le
- Page 32 and 33:
18 2. Non-neoplastic and Proliferat
- Page 34 and 35:
20 2. Non-neoplastic and Proliferat
- Page 36 and 37:
22 2. Non-neoplastic and Proliferat
- Page 38 and 39:
24 2. Non-neoplastic and Proliferat
- Page 40 and 41:
26 2. Non-neoplastic and Proliferat
- Page 42 and 43:
28 2. Non-neoplastic and Proliferat
- Page 44 and 45:
30 2. Non-neoplastic and Proliferat
- Page 46 and 47:
32 2. Non-neoplastic and Proliferat
- Page 48 and 49:
34 2. Non-neoplastic and Proliferat
- Page 50 and 51:
36 2. Non-neoplastic and Proliferat
- Page 52 and 53:
38 2. Non-neoplastic and Proliferat
- Page 54 and 55:
40 2. Non-neoplastic and Proliferat
- Page 56 and 57:
42 2. Non-neoplastic and Proliferat
- Page 58 and 59:
Figure 2.26. Lactational change. Hy
- Page 60 and 61:
46 2. Non-neoplastic and Proliferat
- Page 62 and 63:
48 2. Non-neoplastic and Proliferat
- Page 64 and 65:
50 2. Non-neoplastic and Proliferat
- Page 66 and 67:
52 2. Non-neoplastic and Proliferat
- Page 68 and 69:
54 2. Non-neoplastic and Proliferat
- Page 70 and 71:
56 2. Non-neoplastic and Proliferat
- Page 72 and 73:
58 3. Benign and Borderline TumorsC
- Page 74 and 75:
60 3. Benign and Borderline TumorsF
- Page 76 and 77:
62 3. Benign and Borderline TumorsF
- Page 78 and 79:
64 3. Benign and Borderline TumorsF
- Page 80 and 81:
66 3. Benign and Borderline TumorsF
- Page 82 and 83:
68 3. Benign and Borderline Tumors
- Page 84 and 85:
70 3. Benign and Borderline TumorsF
- Page 86 and 87:
72 3. Benign and Borderline TumorsF
- Page 88 and 89:
74 3. Benign and Borderline Tumors
- Page 90 and 91:
76 3. Benign and Borderline Tumors
- Page 92 and 93:
78 3. Benign and Borderline Tumors
- Page 94 and 95:
80 3. Benign and Borderline Tumors
- Page 96 and 97:
82 3. Benign and Borderline TumorsF
- Page 98 and 99:
84 3. Benign and Borderline TumorsG
- Page 100 and 101:
86 4. Primary Malignant Tumors• M
- Page 102 and 103:
88 4. Primary Malignant TumorsFigur
- Page 104 and 105:
90 4. Primary Malignant TumorsFigur
- Page 106 and 107:
92 4. Primary Malignant TumorsHisto
- Page 108 and 109:
94 4. Primary Malignant TumorsFigur
- Page 110 and 111:
96 4. Primary Malignant TumorsFigur
- Page 112 and 113:
98 4. Primary Malignant TumorsFigur
- Page 114 and 115:
100 4. Primary Malignant TumorsFigu
- Page 116 and 117:
102 4. Primary Malignant TumorsFigu
- Page 118 and 119:
104 4. Primary Malignant Tumors•
- Page 120 and 121:
106 4. Primary Malignant Tumors•
- Page 122 and 123:
108 4. Primary Malignant Tumors•
- Page 124 and 125:
110 4. Primary Malignant TumorsFigu
- Page 126 and 127:
112 4. Primary Malignant TumorsFigu
- Page 128 and 129:
114 4. Primary Malignant TumorsFigu
- Page 130 and 131:
116 4. Primary Malignant TumorsPitf
- Page 132 and 133:
118 4. Primary Malignant TumorsPitf
- Page 134 and 135: 120 4. Primary Malignant TumorsInfl
- Page 136 and 137: 122 4. Primary Malignant Tumors•
- Page 138 and 139: 124 4. Primary Malignant TumorsPitf
- Page 140 and 141: 126 4. Primary Malignant TumorsFigu
- Page 142 and 143: 128 4. Primary Malignant TumorsFigu
- Page 144 and 145: 130 4. Primary Malignant TumorsPitf
- Page 146 and 147: 132 4. Primary Malignant TumorsFigu
- Page 148 and 149: 134 4. Primary Malignant TumorsClin
- Page 150 and 151: 136 4. Primary Malignant Tumorsdiag
- Page 152 and 153: 5Metastatic and SecondaryTumorsMeta
- Page 154 and 155: 140 5. Metastatic and Secondary Tum
- Page 156 and 157: 142 5. Metastatic and Secondary Tum
- Page 158 and 159: Figure 5.6. Metastatic small cell c
- Page 160 and 161: BFigure 5.9. (B) Metastatic papilla
- Page 162 and 163: 148 5. Metastatic and Secondary Tum
- Page 164 and 165: 150 5. Metastatic and Secondary Tum
- Page 166 and 167: 152 5. Metastatic and Secondary Tum
- Page 168 and 169: 154 6. Breast Ductal LavageTable 6.
- Page 170 and 171: 156 6. Breast Ductal LavageFigure 6
- Page 172 and 173: 158 6. Breast Ductal LavageFigure 6
- Page 174 and 175: 160 6. Breast Ductal LavageFigure 6
- Page 176 and 177: 162 6. Breast Ductal Lavagecarcinom
- Page 178 and 179: 164 6. Breast Ductal LavageKrishnam
- Page 180 and 181: 166 IndexApocrine carcinomain axill
- Page 182 and 183: 168 IndexDuctal carcinoma (cont.)fi
- Page 186 and 187: 172 IndexLung cancer, 138metastatic
- Page 188 and 189: 174 IndexPapilloma (cont.)invasive